A study was carried out in 2161 quarter milk samples of 550 cows in Durg district Chhattisgarh. Out of 550 animals, 385 (70%) animals were found to be positive for sub clinical mastitis (SCM) by Modified White Side Test (MWST), 432 (78.54%) by Modified California Mastitis Test (MCMT) and 462 (84%) by somatic cell count (SCC). The quarter wise prevalence of sub clinical mastitis was 47.99%, 55.25% and 60.90% by MWST, MCMT and SCC respectively. Prevalence of blind teats was 1.77%. prevalence was highest during second and third lactations and at 5 and 6 years of age. Infection rate was higher during early and late stages of lactation. HF and Jersey cross bred cows were more susceptible than indigenous cows. Microorganisms isolated were predominantly Staphylococci. ABST revealed sensitivity to cefotaxime whereas most of the isolates were resistant to ampicillin.

This study investigated oxyclozanide, a salicylanilide anthelmintic, as an alternative treatment for Methicillin-resistant Staphylococcus aureus (MRSA) in bovine mastitis. With conventional treatments facing challenges due to antibiotic resistance, oxyclozanide demonstrated promising in vitro antimicrobial effect against MRSA isolates. The minimal inhibitory concentration (MIC) ranged from 0.5 to 1.0 μg/ml, indicating its efficacy. Oxyclozanide’s mechanism involved disrupting the transmembrane structure of bacteria, presenting a potential strategy against MRSA. This suggested the repurposing of oxyclozanide as a viable option for combating MRSA in bovine mastitis, prompting further investigation into its precise mechanism and therapeutic potential.